Woodline Partners LP Arcutis Biotherapeutics, Inc. Transaction History

Woodline Partners LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$5.31 - $10.98 $1.57 Million - $3.26 Million	296,494 Added 36.71%	1,104,244 $5.86 Million
Q2 2023 Aug 14, 2023	BUY	$7.51 - $15.0 $841,683 - $1.68 Million	112,075 Added 16.11%	807,750 $7.7 Million
Q1 2023 May 15, 2023	BUY	$10.23 - $17.14 $519,438 - $870,300	50,776 Added 7.87%	695,675 $7.65 Million
Q4 2022 Feb 14, 2023	BUY	$13.96 - $20.4 $1.32 Million - $1.93 Million	94,503 Added 17.17%	644,899 $9.54 Million
Q3 2022 Nov 14, 2022	BUY	$17.85 - $26.95 $9.82 Million - $14.8 Million	550,396 New	550,396 $10.5 Million

193

127M

5.43M

257K

Ticker ARQT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,187,500
Market Cap $560M
Description
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

Stay updated on Woodline Partners LP with notifications on news.